- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Marina Biotech Inc
+ Add to WatchlistMRNA:US
0.2700 USD 0.0200 8.00%As of 17:20:00 ET on 05/21/2013.
Snapshot for Marina Biotech Inc (MRNA)
| Open: | 0.2500 | Day's Range: | 0.2500 - 0.2900 | Volume: | 95,002 |
|---|---|---|---|---|---|
| Previous Close: | 0.2500 | 52wk Range: | 0.1801 - 0.9200 | 1-Yr Rtn: | -58.46% |
Key Statistics for MRNA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2012) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -1.5500 |
| Est. EPS (12/2012) | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 4.42 |
| Shares Outstanding (M) | 16.37 |
| 30 Day Average Volume | 38,189 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 0.6886 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for MRNA
Company Profile & Key Executives for MRNA
Marina Biotech, Inc. is a biopharmaceutical company. The Company researches and develops therapies for inflammatory diseases and cancer using ribonucleic acid chemistry.
| J Michael FrenchChairman/President/CEO | Barry PoliskyChief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
MRNA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page